Tetragon Partners GP Ltd Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001515070
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2025 · 28 positions · Total reported value $474.27M · Top-10 concentration 86.8% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 37.5% · 4 new · 5 cut · 6 exited
Active Share (vs S&P 500): 99.7% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): +7.8% · vs SPY +5.7% · Prev Value $613.69M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): +5.0% · vs SPY +2.8% · Latest Value $730.98M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q4 2025 13F filing, Tetragon Partners GP Ltd disclosed 28 equity positions with a combined reported value of $474.27M. The filing implies a focused portfolio: its ten largest positions account for 86.8% of reported value. HoldingsHub classifies the profile as Small / Focused / Technology Tilt / High Turnover.
The largest disclosed positions as of Q4 2025 were PATH ($286.01M), KGEI ($27.25M), LYFT ($19.37M). By sector, the heaviest allocations are Technology 67.1%, Health Care 21.1%. Versus the prior quarter, allocation shifted toward Technology (+25.0pp), Health Care (+7.7pp) and away from Materials (-1.8pp), Consumer Staples (-2.8pp).
Versus the prior quarter, Tetragon Partners GP Ltd opened 4 new positions, trimmed 5 and fully exited 6, a turnover rate of 37.5% of positions. The portfolio's overlap with the prior quarter was 37% of names.
The largest new positions opened in Q4 2025 were PRAX ($6.76M), RAPT ($4.46M), AGIO ($4.41M).
Of the 6 positions fully exited versus the prior quarter, the largest were BABA ($174.85M), CABO ($20.77M), PRGS ($20.59M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2025)
- PRAX PRAXIS PRECISION MEDICINES I · $6.76M
- RAPT RAPT THERAPEUTICS INC · $4.46M
- AGIO AGIOS PHARMACEUTICALS INC · $4.41M
- HRMY HARMONY BIOSCIENCES HLDGS IN · $3.10M
- NKTR NEKTAR THERAPEUTICS · $2.93M
- MPLT MAPLIGHT THERAPEUTICS INC · $2.89M
- SLN SILENCE THERAPEUTICS PLC · $2.22M
- ZVRA ZEVRA THERAPEUTICS INC · $1.72M
Fully Exited (vs previous quarter)
- BABA ALIBABA GROUP HLDG LTD · prev qtr: $174.85M
- CABO CABLE ONE INC · prev qtr: $20.77M
- PRGS PROGRESS SOFTWARE CORP · prev qtr: $20.59M
- OTLY OATLY GROUP AB · prev qtr: $18.42M
- AG FIRST MAJESTIC SILVER CORP · prev qtr: $7.97M
- CELC CELCUITY INC · prev qtr: $7.44M · history
- TARS TARSUS PHARMACEUTICALS INC · prev qtr: $7.43M
- HYG ISHARES TR · prev qtr: $5.92M
Insider Transactions (Form 4)
Latest Tetragon Partners GP Ltd buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Tetragon Partners GP Ltd files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 36 positions worth $613.69M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 36 positions · $613.69M reported value (Q2 2026)
- Top 10 holdings = 76.6% of reported value
- Largest position: PATH (UIPATH INC CL A) at 54.8%
- Average position size: $17.05M
Sector Tilt
- Information Technology 60.8%
- Health Care 30.2%
- Energy 5.5%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 6 new, 16 added, 7 reduced, 4 exited
- 7 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
17.45M | $286.01M | 60.30% | Add | |
| 2 |
|
6.93M | $27.25M | 5.75% | Reduce | |
| 3 |
|
1.00M | $19.37M | 4.08% | Hold | |
| 4 |
|
9.50M | $18.91M | 3.99% | Hold | |
| 5 |
|
2.20M | $17.12M | 3.61% | Hold | |
| 6 |
|
150.00K | $12.94M | 2.73% | Hold | |
| 7 |
|
2.03M | $10.20M | 2.15% | Reduce | |
| 8 |
|
22.95K | $6.76M | 1.43% | New | |
| 9 |
|
243.80K | $6.62M | 1.40% | Reduce | |
| 10 |
|
96.94K | $6.44M | 1.36% | Add | |
| 11 |
|
194.61K | $5.40M | 1.14% | Hold | |
| 12 |
|
26.93K | $4.92M | 1.04% | Reduce | |
| 13 |
|
248.00K | $4.85M | 1.02% | Add | |
| 14 |
|
143.33K | $4.52M | 0.95% | Reduce | |
| 15 |
|
131.77K | $4.46M | 0.94% | New | |
| 16 |
|
162.02K | $4.41M | 0.93% | New | |
| 17 |
|
166.19K | $4.22M | 0.89% | Reduce | |
| 18 |
|
141.17K | $3.95M | 0.83% | Add | |
| 19 |
|
260.77K | $3.71M | 0.78% | Add | |
| 20 |
|
272.83K | $3.30M | 0.69% | Add | |
| 21 |
|
82.82K | $3.10M | 0.65% | New | |
| 22 |
|
69.29K | $2.93M | 0.62% | New | |
| 23 |
|
11.81K | $2.91M | 0.61% | Add | |
| 24 |
|
164.53K | $2.89M | 0.61% | New | |
| 25 |
|
365.37K | $2.22M | 0.47% | New | |
| 26 |
|
10.00K | $2.19M | 0.46% | Hold | |
| 27 |
|
192.52K | $1.72M | 0.36% | New | |
| 28 |
|
43.76K | $943.09K | 0.20% | New | |
FAQ
What did Tetragon Partners GP Ltd buy in 2025-Q4?
In its 2025-Q4 13F filing, Tetragon Partners GP Ltd reported 28 equity positions worth $474.27M in aggregate; its largest disclosed positions were PATH ($286.01M), KGEI ($27.25M), LYFT ($19.37M).
How large is Tetragon Partners GP Ltd's portfolio?
Tetragon Partners GP Ltd reported $474.27M of long equity holdings across 28 positions as of 2025-Q4. Top-10 holdings account for 86.8% of reported value.
What is Tetragon Partners GP Ltd's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.